The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
The Health and Economic Benefits Associated With Pneumococcal Vaccination of Elderly Persons With Chronic Lung Disease
Open accessAbstract
BACKGROUND: More than 50% of the elderly population has not received pneumococcal vaccination. Uncertainty regarding the benefits of immunization, particularly for noninvasive disease, may contribute to the underuse of pneumococcal vaccine. OBJECTIVE: To assess the health and economic benefits associated with pneumococcal vaccination. METHODS: We conducted a 2-year retrospective cohort study among all elderly members of a staff-model managed care organization who had a baseline diagnosis of chronic lung disease. The study outcomes were assessed over 2 years, from November 15, 1993, through November 14, 1995, and included hospitalizations for pneumonia and influenza, death, and hospitalization costs. Using administrative data, we compared these outcomes for vaccinated and unvaccinated subjects using multivariate models to control for subjects' baseline demographic and health characteristics. The additive benefits of combined influenza and pneumococcal vaccination were also assessed for the 2 influenza seasons included in the study. RESULTS: There were 1898 subjects. Pneumococcal vaccination was associated with significantly lower risks for pneumonia hospitalizations (adjusted risk ratio [RR], 0.57; 95% confidence interval [CI], 0.38-0.84; P=.005) and for death (adjusted RR, 0.71; 95% CI, 0.56-0.91; P = .008). For the control outcome of all nonpneumonia hospitalizations, rates did not differ significantly between the 2 groups (adjusted RR, 0.91; 95% CI, 0.77-1.07; P= .24). During the influenza seasons included in the study, the benefits of pneumococcal and influenza vaccinations were additive, with an adjusted RR of 0.28 (95% CI, 0.14-0.58; P<.001) for the number of hospitalizations for pneumonia and influenza among persons who had received both vaccinations compared with those who had received neither and an adjusted odds ratio of 0.18 (95% CI, 0.11-0.31; P<.001) for death. Over the 2-year outcome period, pneumococcal vaccination was also associated with direct medical care cost savings. CONCLUSIONS: Pneumococcal vaccination of elderly persons with chronic lung disease was associated with fewer hospitalizations for pneumonia, fewer deaths, and direct medical care cost savings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Clinical Epidemiology: A Basic Science for Clinical Medicine.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-825_9 · Cited by 3,476
Surveillance for waterborne-disease outbreaks--United States, 1993-1994.
Kramer, M. H., Herwaldt, B. L., Craun, G. F., Calderon, R. L., & Juranek, D. D. (1996) · PubMed · Cited by 2,152
Guide to Clinical Preventive Services
Wesley Allen, T. (1991) · The Journal of the American Osteopathic Association · doi:10.1515/jom-1991-900515 · Cited by 2,129
Holtzman, D. J., Powell‐Griner, E., Bolen, J. C., & Rhodes, L. (2000) · PubMed · Cited by 1,110
The Protective Efficacy of Polyvalent Pneumococcal Polysaccharide Vaccine
Shapiro, E. D., Berg, A. T., Austrian, R., Schroeder, D., Parcells, V., Margolis, A., Adair, R. K., & Clemens, J. D. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252101 · Cited by 1,051
(1997) · PsycEXTRA Dataset · doi:10.1037/e547512006-001 · Cited by 1,000
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Self-citationGuide to Clinical Preventive Services
&NA; (1997) · The Nurse Practitioner · doi:10.1097/00006205-199705000-00020 · Cited by 906
Clinical Epidemiology: A Basic Science for Clinical Medicine.
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-6-874_2 · Cited by 779
Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations
Butler, J. C. (1993) · JAMA · doi:10.1001/jama.270.15.1826 · Cited by 671
From the Health Care Financing Administration
Wilensky, G. R. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470200020007 · Cited by 635
Prevention effectiveness : a guide to decision analysis and economic evaluation
Haddix, A. C. (1996) · Cited by 576
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
MacLeod, C. M., Hodges, R. G., Heidelberger, M., & Bernhard, W. G. (1945) · Journal of Experimental Medicine · doi:10.1084/jem.82.6.445 · Cited by 518
Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens.
Nichol, K. L., Wuorenma, J., & von Sternberg, T. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.16.1769 · Cited by 484
Validation of self-report of influenza and pneumococcal vaccination status in elderly outpatients
Mac Donald, R., Baken, L., Nelson, A., & Nichol, K. L. (1999) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(98)00159-7 · Cited by 410
Self-citation7. Prevention of Pneumococcal Pneumonia by Vaccination
Austrian, R., Douglas, R. M., Schiffman, G., Coetzee, A. M., Koornhof, H. J., Hayden-Smith, S., & Reid, R. D. W. (1985) · Life with the Pneumococcus · doi:10.9783/9781512800135-009 · Cited by 401
Efficacy of Pneumococcal Vaccine in High-Risk Patients
Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M., Baltch, A. L., Geiseler, P. J., Nadler, J., Richmond, A. S., Smith, R. P., Schiffman, G., Shepard, D. S., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611203152104 · Cited by 395
Prevention effectiveness: A guide to decision analysis and economic evaluation
Roelofs, C. (1997) · American Journal of Industrial Medicine · doi:10.1002/(sici)1097-0274(199701)31:1<123::aid-ajim21>3.0.co;2-3 · Cited by 393
Nichol, K. L., Baken, L., & Nelson, A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-5-199903020-00003 · Cited by 385
Self-citationÖrtqvist, Å., Hedlund, J., Burman, L.-Å., Elbel, E., Höfer, M., Leinonen, M., Lindblad, I., Sundelöf, B., & Kalin, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07358-3 · Cited by 376
Efficacy of Pneumococcal Vaccination in Adults: A Meta-analysis of Randomized Controlled Trials
Fine, M. J. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420230051007 · Cited by 370
Cost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People
Sisk, J. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160053038 · Cited by 362
Protective Efficacy of Pneumococcal Polysaccharide Vaccines
Smit, P. (1977) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1977.03280250039019 · Cited by 350
The Clinical Effectiveness of Pneumococcal Vaccine in the Elderly
SIMS, R. V., STEINMANN, W. C., MCCONVILLE, J. H., KING, L. R., ZWICK, W. C., & SCHWARTZ, J. S. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-653 · Cited by 317
Clinical effectiveness of influenza vaccination in Manitoba.
Fedson, D. S. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510160074032 · Cited by 278
Influenza Vaccine Effectiveness in Preventing Hospitalization for Pneumonia in the Elderly
Foster, D. A., Talsma, A., Furumoto-Dawson, A., Ohmit, S. E., Margulies, J. R., Arden, N. H., & Monto, A. S. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116495 · Cited by 242
Safety of Revaccination With Pneumococcal Polysaccharide Vaccine
Jackson, L. A. (1999) · JAMA · doi:10.1001/jama.281.3.243 · Cited by 239
Clinical Efficacy of Pneumococcal Vaccine in the Elderly
Koivula, I., Stén, M., Leinonen, M., & Mäkelä, P. H. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00149-6 · Cited by 217
Glezen, W. P., Decker, M., & Perrotta, D. M. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.3.550 · Cited by 204
Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control study
Farr, B. M. (1995) · Archives of Internal Medicine · doi:10.1001/archinte.155.21.2336 · Cited by 177
Inefficacy of pneumococcal vaccine in a high-risk population
Forrester, H. L., Jahnigen, D. W., & Marc Laforce, F. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90751-0 · Cited by 168
Kaufman, P. (1947) · Archives of Internal Medicine · doi:10.1001/archinte.1947.00220110058004 · Cited by 123
Pandey, M. R., Daulaire, N., Starbuck, E. S., Houston, R., & McPherson, K. (1991) · The Lancet · doi:10.1016/0140-6736(91)91847-n · Cited by 122
Fleming, D., Watson, J. M., Nicholas, S., Smith, G., & Swan, A. V. (1995) · Epidemiology and Infection · doi:10.1017/s095026880005874x · Cited by 120
Ohmit, S. E., & Monto, A. S. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.6.1240 · Cited by 117
[Clinical trial of an antipneumococcal vaccine in elderly subjects living in institutions].
GAILLAT, J., Zmirou‐Navier, D., Mallaret, M., Rouhan, D., Bru, J. P., Stahl, J. ‐., Delormas, P., & Micoud, M. (1985) · PubMed · Cited by 115
The Pneumococcal Vaccine After 15 Years of Use
Hirschmann, J. V. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420040023005 · Cited by 108
Davis, A. L., Aranda, C. P., Schiffman, G., & Christianson, L. C. (1987) · CHEST Journal · doi:10.1378/chest.92.2.204 · Cited by 103
(1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-102-6-882_1 · Cited by 95
Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.
Leech, J., Gervais, A., & Ruben, F. L. (1987) · Europe PMC (PubMed Central) · Cited by 88
Opportunity Costs In Modern Medicine
Russell, L. B. (1992) · Health Affairs · doi:10.1377/hlthaff.11.2.162 · Cited by 61
Margolis, K. L., Nichol, K. L., Wuorenma, J., & Sternberg, T. V. (1992) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1992.tb04480.x · Cited by 46
Self-citationFedson, D. S. (1994) · Preventive Medicine · doi:10.1006/pmed.1994.1129 · Cited by 42
Simberkoff, M. S. (1993) · PubMed · Cited by 23
Efficacy of pneumococcal polysaccharide vaccine
Scott, P., Huss, A., Stuck, A. E., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.1090018 · Cited by 9
Cited by
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Evaluating non-randomised intervention studies
Deeks, J., Dinnes, J., D'Amico, R., Sowden, A., Sakarovitch, C., Song, F., Petticrew, M., & Altman, D. (2003) · Health Technology Assessment · doi:10.3310/hta7270 · Cited by 2,907
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 960
Guidelines for the management of adult lower respiratory tract infections
Woodhead, M., Blasi, F., Ewig, S., Huchon, G., Leven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., & Verheij, T. J. M. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00055705 · Cited by 895
COPD exacerbations: definitions and classifications
Burge, S., & Wedzicha, J. A. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00078002 · Cited by 664
Metadata
- Authors
- Nichol, K. L., Baken, L., Wuorenma, J., & Nelson, A.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 1999-11-08
- Volume
- 159
- Issue
- 20
- Pages
- 2437
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2110167247
- Cited by
- 297
- References
- 46
- FWCI
- 16.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.